Better co-ordination is essential to foster and accelerate the development and adoption of personalised prevention strategies for the years to come. It will also be important to assess the value of prevention in terms of savings in the health system.

Proposals should address all of the following:

• Identification and networking of key stakeholders for the co-creation of strategies for personalised prevention.
• Literature mapping, research gap analysis and mapping of existing research programmes for personalised prevention in Europe and beyond.
• Identification of existing bottlenecks, analysis of evidences and examples of successful implementation of personalised prevention approaches and assessment of their transferability.
• Analysis of how personalised prevention can be delivered most effectively, efficiently and cost-effective.
• Robust, professional communication strategy to maximise the impact of the findings and the uptake of personalised prevention strategies.
• A Strategic Research and Innovation Agenda on personalised prevention throughout the life course to inform research funders and other prospective partners of the expected future European partnership on personalised medicine.

Proposals should engage with related research initiatives and provide input to prospective partners of the expected future European partnership on personalised medicine.

Proposals should encourage a patient-centred approach that empowers patients, promotes a culture of dialogue and openness between health professionals, patients and their families, and unleashes the potential of social innovation.